NRC HEALTH
NRCUS売上高
$137M
百万USD
営業利益
$23M
百万USD
純利益
-
百万USD
ROE
-
最新FY
EPS
$50.00
USD / 株
配当
$0.52
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $35M | - | $0.36 |
| FY2021 | Q2 | $36M | - | $0.35 |
| FY2021 | Q3 | $38M | - | $0.38 |
| FY2021 | FY | $148M | - | $1.46 |
| FY2022 | Q1 | $38M | - | $0.34 |
| FY2022 | Q2 | $37M | - | $0.33 |
| FY2022 | Q3 | $38M | - | $0.33 |
| FY2022 | FY | $152M | - | $1.27 |
| FY2023 | Q1 | $36M | - | $0.28 |
| FY2023 | Q2 | $36M | - | $0.29 |
| FY2023 | Q3 | $38M | - | $0.32 |
| FY2023 | FY | $149M | - | $1.25 |
| FY2024 | Q1 | $35M | - | $0.27 |
| FY2024 | Q2 | $35M | - | $0.26 |
| FY2024 | Q3 | $36M | - | $0.24 |
| FY2024 | FY | $143M | - | $1.04 |
| FY2025 | Q1 | $34M | - | $0.25 |
| FY2025 | Q2 | $34M | - | $-0.01 |
| FY2025 | Q3 | $35M | - | $0.18 |
| FY2025 | FY | $137M | - | $50.00 |
| FY2026 | Q1 | $35M | - | $0.14 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $128M | $133M | $148M | $152M | $149M | $143M | $137M |
| 営業利益 | $31M | $34M | $35M | $43M | $43M | $50M | $47M | $40M | $35M | $23M |
| 純利益 | $21M | $23M | $30M | - | - | - | - | - | - | - |
| 総資産 | $121M | $127M | $108M | $111M | $133M | $158M | $130M | $122M | $133M | $135M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $83M | $90M | $19M | $33M | $64M | $85M | $72M | $49M | $31M | $14M |
| 営業CF | $27M | $28M | $40M | $41M | $41M | $46M | $36M | $38M | $35M | $26M |
| EPS | - | - | - | - | - | $1.46 | $1.27 | $1.25 | $1.04 | $50.00 |
| BPS | - | - | $0.77 | $1.31 | $2.53 | $3.39 | $2.93 | $2.05 | $1.36 | $0.62 |
| ROE | 24.8% | 25.5% | 157.5% | - | - | - | - | - | - | - |